Somulose Solution for Injection

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Secobarbital sodium ; Cinchocaine Hydrochloride

Available from:

Dechra Ltd

ATC code:

QN05CB02

INN (International Name):

Secobarbital sodium ; Cinchocaine Hydrochloride

Dosage:

400/25 milligram(s)/millilitre

Pharmaceutical form:

Solution for injection

Prescription type:

VPO: Veterinary Practitioner Only as defined in relevant national legislation

Therapeutic group:

Cats, Cattle, Dogs, Non food-producing horses

Therapeutic area:

barbiturates in combination with other drugs

Therapeutic indications:

Neurological Preparations

Authorization status:

Authorised

Authorization date:

2006-10-06

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Somulose Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear slightly straw coloured viscous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats, horses and cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For euthanasia in dogs, cats, horses and cattle only.
4.3 CONTRAINDICATIONS
The combination product must not be used for anaesthesia, it is
non-sterile.
When used in horses or cattle do not use the carcass for animal
consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Non-vascular administration may delay onset of effect, cause pain and
result in excitement.
Rarely, horses may show resistance to euthanasia and prior use of
sedation should be considered in each case (see also
under section 4.9). It is always advisable to have an alternative
method of euthanasia available.
1 ml contains:
ACTIVE SUBSTANCES:
Secobarbital Sodium (Quinalbarbitone Sodium)
400 mg
Cinchocaine Hydrochloride
25
mg
For the full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_5_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_1_
_1_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Care should be taken not to excite the animal.
The dose is to be administered intravenously only (see also under
section